Sagimet Biosciences Inc.(SGMT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SGMT Sagimet Biosciences Inc.

盘前交易 02-05 06:59:21 EST

6.08

-0.48

-7.32%

盘前6.33

+0.25+4.11%

06:38 EST

最高6.67	最低5.95	成交量92.96万
今开6.61	昨收6.56	日振幅11.05%
总市值1.98亿	流通市值1.38亿	总股本3,252万
成交额568.75万	换手率4.11%	流通股本2,263万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SGMT","market":"US","secType":"STK","nameCN":"Sagimet Biosciences Inc.","latestPrice":6.08,"timestamp":1770238800000,"preClose":6.56,"halted":0,"volume":929598,"hourTrading":{"tag":"盘前","latestPrice":6.33,"preClose":6.08,"latestTime":"06:38 EST","volume":2,"amount":12.66,"timestamp":1770291522147,"change":0.25,"changeRate":0.041118,"amplitude":0},"delay":0,"changeRate":-0.07317073170731701,"floatShares":22626486,"shares":32521599,"eps":-1.786134,"marketStatus":"盘前交易","change":-0.48,"latestTime":"02-05 06:59:21 EST","open":6.61,"high":6.67,"low":5.945,"amount":5687510.639505,"amplitude":0.110518,"askPrice":6.3,"askSize":200,"bidPrice":5.54,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.786134,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770301800000},"marketStatusCode":1,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":6.08,"preHourTrading":{"tag":"盘前","latestPrice":6.33,"preClose":6.08,"latestTime":"06:38 EST","volume":2,"amount":12.66,"timestamp":1770291522147,"change":0.25,"changeRate":0.041118,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":6.0708,"preClose":6.08,"latestTime":"19:54 EST","volume":6499,"amount":39568.578,"timestamp":1770252892767,"change":-0.0092,"changeRate":-0.001513,"amplitude":0.022796},"volumeRatio":0.5955870895852106,"impliedVol":1.2439,"impliedVolPercentile":0.488},"requestUrl":"/m/hq/s/SGMT","defaultTab":"news","newsList":[{"id":"2608899870","title":"华尔街顶级分析师最新评级：奥多比遭下调，帕兰提尔获上调","url":"https://stock-news.laohu8.com/highlight/detail?id=2608899870","media":"环球市场播报","labels":["rating"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608899870?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:46","pubTimestamp":1770129960,"startTime":"0","endTime":"0","summary":"华尔街最受关注、对市场影响显著的分析师评级报告现已汇总呈现。以下为 The Fly 整理的、投资者需重点关注的今日最新评级调整信息。该行称，估值因素是此次评级下调的核心原因，目前埃克森美孚的市盈率处于五年高位。该行对阿克蒂斯肿瘤的发展前景持积极态度：公司正致力于拓展放射性药物的治疗靶点领域，其管线项目有望成为首款同类创新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-03/doc-inhkqfvc7106899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1823568750.SGD","LU0109392836.USD","LU0158827948.USD","LU0006306889.USD","LU0511384066.AUD","SGXZ81514606.USD","LU0342679015.USD","BK4588","LU0965509283.SGD","IE00BYQQ9H92.USD","LU0345774631.USD","JBLU","CTRA","IE00B19Z9505.USD","LU0472753341.HKD","BK4554","LU2125154778.USD","SG9999000418.SGD","IE00BQXX3D17.EUR","XOM","BK4566","LU0081259029.USD","PLTR","BK4543","LU1267930813.SGD","LU1674673691.USD","IE00BFXG0V08.USD","LU0082616367.USD","LU1548497426.USD","LU2023251221.USD","LU0957791311.USD","LU0965509101.SGD","LU0792757196.USD","LU1674673428.USD","LU2236285917.USD","BK4581","LU0061474960.USD","BK4533","ADBE","AFRM","BK4592","LU0314104364.USD","BK4534","LU0057025933.USD","BK4023","LU0708995401.HKD","LU2360032135.SGD","LU2357305700.SGD","LU0234572021.USD","LU2458330243.SGD","LU2317271919.USD","LU0069063385.USD","LU1778281490.HKD","LU0157215616.USD","LU1720051017.SGD","FIGR","LU1623119135.USD","IE00B5TLWC47.USD","TASK","LU1084165304.USD","LU2237438978.USD","LU1366333091.USD","LU1815333072.USD","LU1267930730.SGD","QTWO","LU0965509010.AUD","LU2089283258.USD","LU0719512351.SGD","LU0234570918.USD","LU0348723411.USD","LU0106261372.USD","LU0109391861.USD","LU0672654240.SGD","IE0009356076.USD","LU0289739343.SGD","LU2210150020.SGD","LU0198837287.USD","ELV","SGXZ99366536.SGD","LU1261432733.SGD","LU0868494708.USD","IE00BQXX3C00.GBP","LU2125154935.USD","IE00BQXX3F31.USD","MA","LU1235294995.USD","LU1633808545.USD","LU2089284900.SGD","LU0868494617.USD","LU0345774391.USD","SG9999001424.SGD","LU1720051108.HKD","BK4527","LU2458330169.SGD","SGXZ51526630.SGD","LU1803068979.SGD","LU2210149790.SGD","LU1119994496.HKD","DIS","BK4528","LU0320765059.SGD","LU0557290698.USD","LU2095319765.USD","LU0942090050.USD","LU0170899867.USD","LU1046421795.USD","LU0889565833.HKD","BK4567","BK4585","LU0289961442.SGD","LU1712237335.SGD","LU1691799644.USD","AKTS","STAA","SGMT","LU0889566641.SGD","LU0861579265.USD"],"gpt_icon":1},{"id":"1115094397","title":"Sagimet公布授权合作伙伴歌礼制药开放式三期临床试验52周积极数据，评估Asc40（Denifanstat）片剂中重度痤疮患者长期安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=1115094397","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115094397?lang=zh_cn&edition=full","pubTime":"2026-02-02 20:02","pubTimestamp":1770033746,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences Inc. 今日宣布，其授权合作伙伴歌礼制药在一项开放式三期临床试验中取得了为期52周的积极数据。该试验重点评估了Asc40（Denifanstat）片剂用于中重度痤疮患者的长期安全性。\n数据显示，在整个52周的治疗期内，Asc40（Denifanstat）片剂展现出良好的安全性与耐受性特征。这一积极结果为进一步评估该药物治疗痤疮的潜力和长期应用前景提供了有力支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2605236900","title":"Sagimet Biosciences Inc. - Series A盘中异动 临近午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605236900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605236900?lang=zh_cn&edition=full","pubTime":"2026-01-24 00:36","pubTimestamp":1769186183,"startTime":"0","endTime":"0","summary":"北京时间2026年01月24日00时36分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅下挫5.00%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体跌幅为0.42%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124003623a6a5cfc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124003623a6a5cfc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2593144756","title":"Sagimet Biosciences Inc. - Series A盘中异动 临近收盘快速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593144756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593144756?lang=zh_cn&edition=full","pubTime":"2025-12-20 04:37","pubTimestamp":1766176679,"startTime":"0","endTime":"0","summary":"北京时间2025年12月20日04时37分，Sagimet Biosciences Inc. - Series A股票出现异动，股价快速拉升5.03%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为1.28%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220043759a4615953&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220043759a4615953&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"1141511236","title":"Sagimet Biosciences发布Denifanstat和Resmetirom联合用药的一期PK临床试验积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1141511236","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141511236?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:01","pubTimestamp":1766059299,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences发布Denifanstat和Resmetirom联合用药的一期PK临床试验积极结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"1159376043","title":"Sagimet Biosciences - Denifanstat与Resmetirom的联合试验正在进行中，预计2025年底将公布初步数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1159376043","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159376043?lang=zh_cn&edition=full","pubTime":"2025-12-17 20:09","pubTimestamp":1765973372,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences - Denifanstat与Resmetirom的联合试验正在进行中，预计2025年底将公布初步数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2588063982","title":"Sagimet Biosciences Inc. - Series A盘中异动 急速跳水5.00%报6.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588063982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588063982?lang=zh_cn&edition=full","pubTime":"2025-12-03 01:51","pubTimestamp":1764697913,"startTime":"0","endTime":"0","summary":"北京时间2025年12月03日01时51分，Sagimet Biosciences Inc. - Series A股票出现异动，股价大幅下跌5.00%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.38%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203015154a4c88b9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203015154a4c88b9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2585274165","title":"Sagimet Biosciences Inc. - Series A盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585274165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585274165?lang=zh_cn&edition=full","pubTime":"2025-11-21 04:02","pubTimestamp":1763668977,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日04时02分，Sagimet Biosciences Inc. - Series A股票出现波动，股价急速跳水5.08%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.50%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121040257a4afe246&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121040257a4afe246&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2582337832","title":"Sagimet Biosciences Inc. - Series A盘中异动 股价大涨5.25%报7.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582337832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582337832?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:39","pubTimestamp":1762785593,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时39分，Sagimet Biosciences Inc. - Series A股票出现波动，股价快速拉升5.25%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.67%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110223953a6efc1fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110223953a6efc1fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2574168754","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘快速拉升6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574168754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574168754?lang=zh_cn&edition=full","pubTime":"2025-10-09 21:31","pubTimestamp":1760016709,"startTime":"0","endTime":"0","summary":"北京时间2025年10月09日21时31分，Sagimet Biosciences Inc. - Series A股票出现波动，股价快速拉升6.02%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体跌幅为0.13%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009213149a4585ffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009213149a4585ffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"1162093241","title":"Sagimet Biosciences宣布Denifanstat和Resmetirom联合用药1期药代动力学临床试验首批参与者开始给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1162093241","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162093241?lang=zh_cn&edition=full","pubTime":"2025-10-01 19:02","pubTimestamp":1759316572,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences公司宣布，其Denifanstat和Resmetirom联合用药的1期药代动力学临床试验已开始对首批参与者进行给药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2569167707","title":"Sagimet Biosciences Inc. - Series A盘中异动 急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569167707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569167707?lang=zh_cn&edition=full","pubTime":"2025-09-22 23:29","pubTimestamp":1758554955,"startTime":"0","endTime":"0","summary":"北京时间2025年09月22日23时29分，Sagimet Biosciences Inc. - Series A股票出现异动，股价大幅拉升5.06%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.77%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092223291697a2b1d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092223291697a2b1d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"1196381432","title":"合作伙伴Ascletis将在2025年EADV大会上展示Denifanstat治疗中重度痤疮的积极三期临床结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1196381432","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196381432?lang=zh_cn&edition=full","pubTime":"2025-09-17 19:01","pubTimestamp":1758106899,"startTime":"0","endTime":"0","summary":"合作伙伴Ascletis将在2025年EADV大会上展示Denifanstat治疗中重度痤疮的积极三期临床结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2562729399","title":"Sagimet Biosciences Inc. - Series A盘中异动 快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562729399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562729399?lang=zh_cn&edition=full","pubTime":"2025-08-27 23:23","pubTimestamp":1756308226,"startTime":"0","endTime":"0","summary":"北京时间2025年08月27日23时23分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅拉升5.00%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.16%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508272323479500c558&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508272323479500c558&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MT","SGMT","BK4561","BK4006"],"gpt_icon":0},{"id":"2558866487","title":"Sagimet Biosciences Inc. - Series A盘中异动 急速拉升5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558866487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558866487?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:55","pubTimestamp":1754927754,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时55分，Sagimet Biosciences Inc. - Series A股票出现异动，股价快速上涨5.38%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.26%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂，旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081123555494dcf5d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081123555494dcf5d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2518716122","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大跌5.03%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518716122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518716122?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:36","pubTimestamp":1741617379,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时36分，Sagimet Biosciences Inc. - Series A股票出现异动，股价快速下挫5.03%。截至发稿，该股报3.50美元/股，成交量12.7763万股，换手率0.40%，振幅6.39%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.02%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022362096404608&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022362096404608&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2516668736","title":"Sagimet Biosciences Inc. - Series A盘中异动 下午盘股价大跌5.25%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516668736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516668736?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:14","pubTimestamp":1741032869,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时14分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅下跌5.25%。截至发稿，该股报3.52美元/股，成交量36.6198万股，换手率1.14%，振幅6.94%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.04%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304041429989a5bfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304041429989a5bfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2514041389","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514041389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514041389?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:15","pubTimestamp":1740669353,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时15分，Sagimet Biosciences Inc. - Series A股票出现波动，股价快速拉升5.21%。截至发稿，该股报4.04美元/股，成交量8.3992万股，换手率0.26%，振幅3.69%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.99%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231553989519d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231553989519d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2513720995","title":"Sagimet Biosciences Inc. - Series A盘中异动 股价大跌5.55%报3.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720995?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:05","pubTimestamp":1740409502,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时05分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅下挫5.55%。截至发稿，该股报3.89美元/股，成交量15.5735万股，换手率0.48%，振幅6.31%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.45%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230502a2521cd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230502a2521cd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2512193878","title":"Sagimet Biosciences Inc. - Series A盘中异动 股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512193878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512193878?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:53","pubTimestamp":1739901213,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时53分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅跳水5.18%。截至发稿，该股报4.03美元/股，成交量52.0051万股，换手率1.62%，振幅10.12%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.66%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219015333a24ad74e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219015333a24ad74e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sagimet.com","stockEarnings":[{"period":"1week","weight":0.0384},{"period":"1month","weight":0.0975},{"period":"3month","weight":-0.2094},{"period":"6month","weight":-0.3036},{"period":"1year","weight":0.1945},{"period":"ytd","weight":0.027}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0022},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.0769},{"period":"1year","weight":0.1403},{"period":"ytd","weight":0.0063}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sagimet Biosciences Inc.于2006年12月19日在特拉华州注册成立，名称为3-V Biosciences，Inc.，总部位于加利福尼亚州圣马特奥。该公司于2019年8月将其名称从3-V Biosciences，Inc.更改为Sagimet Biosciences Inc.。该公司是临床阶段的生物制药公司，致力于开发内部发现的选择性脂肪酸合酶抑制剂组合，用于治疗因脂质代谢功能障碍而导致的疾病。","exchange":"NASDAQ","name":"Sagimet Biosciences Inc.","nameEN":"Sagimet Biosciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sagimet Biosciences Inc.(SGMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sagimet Biosciences Inc.(SGMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sagimet Biosciences Inc.,SGMT,Sagimet Biosciences Inc.股票,Sagimet Biosciences Inc.股票老虎,Sagimet Biosciences Inc.股票老虎国际,Sagimet Biosciences Inc.行情,Sagimet Biosciences Inc.股票行情,Sagimet Biosciences Inc.股价,Sagimet Biosciences Inc.股市,Sagimet Biosciences Inc.股票价格,Sagimet Biosciences Inc.股票交易,Sagimet Biosciences Inc.股票购买,Sagimet Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sagimet Biosciences Inc.(SGMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sagimet Biosciences Inc.(SGMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}